This virtual meeting is directed by leading infectious disease specialists Dr. Charles Flexner and Dr. Daniel Kurtitzkes, and provides a platform for cross-talk between experts from different disciplines that will catalyze knowledge transfer on comprehending technology, pharmacological properties, discovery and preclinical development, and recent clinical data on monoclonal antibodies.
Important: 5 complimentary registrations (first 5 applications) and a 25% discount code for all NVF members.
In order to use the discounts please use the following codes:
- 100% registration waiver – MABS100DUT (for the first 5 applicants)
- 25% discount code – MABS25DUT (for all other NVF members)

